Hepatitis C Investment Impact: Maximizing Healt...

By João L. Carapinha

May 14, 2025

The economic ramifications of hepatitis C (HCV) are staggering. Estimates suggest the disease could impose a $1.17 trillion burden on China from 2023 to 2050. This is the crux of the hepatitis C investment impact article we cover below, meeting WH...
First At-Home HPV Testing Approval: FDA Clears Teal Wand
MR-107A-02: Revolutionizing Non-Opioid Pain Management with Viatris’ Breakthr...
Bulevirtide HDV Therapy: Promising Results in Durable Virologic Control
FDA AI Drug Approval
TAVR Asymptomatic Approval: A New Era for Early Intervention in Aortic Stenosis
Ivonescimab NMPA Approval Signals Breakthrough in Lung Cancer
ZEVASKYN Gene Therapy: A Breakthrough for Recessive Dystrophic Epidermolysis ...
Trodelvy Keytruda Combination Delivers Breakthrough Results in Metastatic Tri...
AI Pediatric Sarcoma Diagnosis: Improving Speed and Accuracy in Cancer Classi...
Urgent Need for Pediatric Heart Devices
Journavx for Pain Management: Toward Affordability and Access
FDA Approves Perioperative Immunotherapy for Bladder Cancer: A Breakthrough i...